A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer.

Trial Profile

A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer.

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Jan 2013

At a glance

  • Drugs Anastrozole (Primary)
  • Indications Advanced breast cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 29 Jan 2013 Actual end date (Nov 2007) added as reported by ClinicalTrials.gov.
    • 20 Jan 2011 Actual initiation date changed from Aug 2004 to Jun 2005 as reported by ClinicalTrials.gov.
    • 26 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top